Revenue Decline Amid Weak Demand
Q1 2026 revenue fell 6.3% YoY to $7.20B from $7.68B, reflecting continued softness in petrochemical end markets and pricing pressure across key product segments.
Source: 10-Q Financial Data, Income Statement
Computed from published fixed rules, not a model's judgement — though one input, the count of high-severity risks, comes from the AI analysis below.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
LyondellBasell (LYB) reported Q1 2026 revenue of $7.20B (down 6.3% YoY) while operating income more than doubled to $239M, though EPS fell 29.6% to $0.38 and operating cash flow remained negative at -$269M.
Revenue
$7.2B
-6.25% YoY
EPS (Diluted)
$0.38
-29.63% YoY
Operating Income
$239M
+109.65% YoY
Source: SEC XBRL
LyondellBasell Industries N.V (LYB) reported Q1 FY2026 revenue of $7.2B, down 6.3% year over year. Operating margin was 3.3%, up 1.8 points from 1.5% a year earlier. Operating cash flow was negative $269M. LYB's fiscal Q1 FY2026 corresponds to calendar Q1 2026.
Last 4 quarters: 3 beats
| Quarter | Actual EPS (USD) | Consensus (USD) | Result |
|---|---|---|---|
| Jun 2026 | 4.30 | 3.45 | Beat +24.7% |
| Mar 2026This filing | 0.49 | 0.20 | Beat +140.4% |
| Dec 2025 | -0.26 | 0.13 | Miss -299.7% |
| Sep 2025 | 1.01 | 0.81 | Beat +24.2% |
Adjusted (non-GAAP) EPS of $0.49 versus the $0.20 analyst consensus — a +140.4% beat for Mar 2026. Analyst consensus is quoted on the adjusted (non-GAAP) basis the street uses. GAAP diluted EPS for this quarter was $0.38.
Compiled by AI from this SEC filing
Q1 2026 revenue fell 6.3% YoY to $7.20B from $7.68B, reflecting continued softness in petrochemical end markets and pricing pressure across key product segments.
Source: 10-Q Financial Data, Income Statement
Operating income surged 109.6% YoY to $239M from $114M, driven by a sharper decline in cost of revenue (-8.9% to $6.50B) relative to the revenue drop, implying improved cost discipline and/or favorable feedstock costs.
Source: 10-Q Financial Data, Income Statement
Operating margin improved to 3.32% from 1.48% in Q1 2025, a gain of approximately 183 basis points YoY, suggesting meaningful cost structure improvement even as top-line revenue contracted.
Source: 10-Q Financial Data, Key Ratios
Cash and equivalents rose 41.1% YoY to $2.64B from $1.87B, even as operating cash flow remained negative at -$269M (improved from -$579M in Q1 2025), indicating asset monetization or working capital management contributed to the cash build.
Source: 10-Q Financial Data, Balance Sheet & Cash Flow
Stockholders' equity fell 17.8% YoY to $10.04B from $12.21B, while current liabilities rose 15.2% to $7.19B, signaling increased near-term financial obligations and potential balance sheet pressure.
Source: 10-Q Financial Data, Balance Sheet
Compiled by AI from this SEC filing · 2 high, 2 medium, 1 low
LYB generated negative operating cash flow of -$269M in Q1 2026, though this improved from -$579M in Q1 2025. Sustained negative operating cash flow limits the company's ability to fund capital expenditures, dividends, and debt repayment from internal sources.
Source: 10-Q Financial Data, Cash Flow Statement
Stockholders' equity dropped 17.8% YoY to $10.04B while current liabilities surged 15.2% to $7.19B. This combination tightens the balance sheet and could pressure the company's financial flexibility and credit profile.
Source: 10-Q Financial Data, Balance Sheet
Revenue declined 6.3% YoY to $7.20B, reflecting weak demand and pricing in core petrochemical markets. If end-market demand does not recover, top-line pressure may persist and erode the margin gains achieved through cost reductions.
Source: 10-Q Financial Data, Income Statement
Basic and diluted EPS fell 29.6% YoY to $0.38 despite operating income more than doubling, suggesting significant below-the-line charges (e.g., interest expense, taxes, or non-operating items) are weighing heavily on net income available to shareholders.
Source: 10-Q Financial Data, Income Statement
Share repurchases dropped to $0 in Q1 2026 from $110M in Q1 2025, a 100% reduction, indicating management is conserving cash amid uncertain market conditions and negative operating cash flow, which may signal reduced confidence in near-term cash generation.
Source: 10-Q Financial Data, Cash Flow Statement
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue $B | 7.20 $B | 7.68 $B | -6.25% |
Cost of Revenue $B | 6.50 $B | 7.13 $B | -8.87% |
Operating Income $M | 239.00 $M | 114.00 $M | +109.65% |
EPS (Basic) $ | 0.38 $ | 0.54 $ | -29.63% |
EPS (Diluted) $ | 0.38 $ | 0.54 $ | -29.63% |
R&D Expense $M | 36.00 $M | 34.00 $M | +5.88% |
SG&A Expense $M | 411.00 $M | 401.00 $M | +2.49% |
Answers draw on this SEC filing and the data on this page
LyondellBasell Industries N.V. (LYB) reported strong financial results in Q2 FY2026 with revenue rising 19.8% YoY to $9.18B and operating income jumping 441.4% YoY to $1.54B, driven by margin expansion amid Middle East supply constraints, despite absorbing a $734M pre-tax loss on European asset divestitures.
LYB reported a sharp reversal to an operating loss of -$420M in FY2025, with revenue declining 9.7% to $30.2B and EPS swinging to -$2.34, reflecting severe margin compression across its chemical operations.
Other companies in Specialty Chemicals